NM_173481.4(MISP):c.1002G>A (p.Leu334=) AND not provided
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Jul 1, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003423141.9
Allele description [Variation Report for NM_173481.4(MISP):c.1002G>A (p.Leu334=)]
NM_173481.4(MISP):c.1002G>A (p.Leu334=)
Condition(s)
- Synonyms:
- none provided
- Identifiers:
- MedGen: C3661900
-
Homo sapiens transmembrane protein 169 (TMEM169), transcript variant 3, mRNA
Homo sapiens transmembrane protein 169 (TMEM169), transcript variant 3, mRNAgi|1676317098|ref|NM_138390.4|Nucleotide
-
Results - NTP Technical Report on the Toxicity Studies of Trans-resveratrol (CAS...
Results - NTP Technical Report on the Toxicity Studies of Trans-resveratrol (CASRN 501-36-0) Administered by Gavage for Two Weeks or Three Months to F344/NTac Rats, Wistar Han [Crl:WI(Han)] Rats, and B6C3F1/N Mice
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Oct 8, 2024